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Background: The impact of vessel patency on long-term clinical outcomes following revascularization for critical limb ischemia (CLI) is uncertain. 
We compared patency rates and clinical outcomes among patients with CLI and claudication after percutaneous femoral artery revascularization.
Methods: We followed a cohort of 171 limbs in 136 consecutive patients at two institutions after successful revascularization. Patients were 
followed for 2.5 years, and survival analysis used to compare outcomes for critical limb ischemia (n=25) and claudication (n=128). Major adverse 
event (MAVE) was defined as failed primary patency, death or amputation.
Results: Compared to claudicants, patients with CLI were older (mean age 67 yrs. vs. 73 yrs, p=0.016) and more had chronic kidney disease (22% 
vs. 40%, p=0.07). Compared to claudicants, patients with CLI had longer lesions (148 mm vs. 216 mm, p=0.07), more total occlusions (42% vs. 
76%, p=0.002), and more TASCII C or D lesions (36% vs. 72%, p=0.001). Compared to claudicants, revascularized CLI lesions had similar failed 
primary (adjusted HR=1.1, p=0.89) and secondary patency (adjusted HR=1.1, p=0.95), but had more MAVE (HR 2.3, p=0.028) (Figure).
Conclusion: Although, CLI had a higher risk of long-term death and amputation, patency rates for successfully revascularized limbs were similar. 
Co-morbidities, rather than patency, more likely affect long-term clinical outcome and highlight the importance of overall cardiovascular care in 
patients with CLI.
